1st Summit 2019


The first Summit 2019, dedicated to the regulatory impacts and the new European Medical Device Directive, that took place on the 11th of March in São Paulo was a big success! This event organised by ELS Solutions and by Vera Rosas counted with speakers as the CEO of ELS Solutions, Dr Diogo Sousa-Martins, and Dr Mariana Camões, Regulatory and Quality Affairs Specialist also from ELS Solutions.

Technology in the change of modern medicine


We all know that today technology and medicine go hand in hand, much has been done in this area, nanotechnology is proof of that, especially in cancer treatments. Far are the days of exclusive use of methods from other generations, nanotechnology made an important progress in the fight against this dreaded disease, the one of the most prevalent throughout the world.
The use of this advanced technology in diagnostic procedures, makes us think that the future is now and much more can be done, not only in oncology, but also in other areas of medicine for the good of Humanity and Science.
ELS Solutions monitors and develops several actions in these areas, helping our customers and partners to find innovative solutions.

Falsified medicines directive


In europe, from 9th of February on, the presence of a unique identifier (a two-dimensional bar-code) is complimentary in medicinal products for human use, as well as a security system on the outer packaging, which indicates whether the packaging was opened or altered after leaving the manufacturer and guarantees the authenticity of the content. This measure is part of the falsified medicines directive and it will be applied in all member states, except for Greece and Italy, which have until 2025 to update their traceability systems.

For more information, please check the European Medicines Agency website here,  and the INFARMED, I.P.’s communication .

At ELS Solutions, we have a rigorous and vigilant regulatory affairs team, watching for changes in legislation, no matter what your market is. We are here to help you comply with legal requisites, make the most of your time and become even more competitive!

Valentine’s Day


On Valentine’s Day, ELS Solutions will tell you how Artificial Intelligence (AI) is about to advance the cardiovascular disease field:

– Identification of novel drugs;
– Determination of who is most likely to benefit from certain interventions, based on genetic information, environment and lifestyle;
– Integration of data from varied sources (wearables, social media, etc) and prediction of disease;
– Remote monitoring of disease using wearables.

For more information, check the American College of Cardiology’s article here »

ELS Solutions partners also with cardiovascular innovators in the field of medical devices and drugs. ELSy® is our patented AI-powered matchmaking pipeline program where you can obtain all innovative pipeline in this field.

Innovation is our passion! Become our partner and innovate with us!